Brazil And The Defence Of Public Health: Do As I Say, Not As I Do
A recent decision issued by Advocacia-Geral da União (Advocacy-General of the Union) restricts the role performed by Anvisa - the National Agency for Health Surveillance - in examining pharmaceutical patent applications. This may represent a huge setback for commitments made by Brazilian government related to the protection of public health, writes Felipe Carvalho.
